MBRX logo

Moleculin Biotech (MBRX) Shareholders Equity

MBRX Annual Shareholders Equity

$26.07 M
-$26.12 M-50.04%

31 December 2023

MBRX Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MBRX Quarterly Shareholders Equity

$7.48 M
-$10.23 M-57.76%

30 September 2024

MBRX Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MBRX Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.0%-65.3%
3 y3 years+46.8%-81.4%
5 y5 years+82.7%-81.4%

MBRX Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-67.0%at low-90.5%at low
5 y5-year-67.0%+67.5%-91.5%at low
alltimeall time-67.0%+3601.1%-91.5%+1186.6%

Moleculin Biotech Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$7.48 M(-57.8%)
June 2024
-
$17.70 M(-18.0%)
Mar 2024
-
$21.59 M(-17.2%)
Dec 2023
$26.07 M(-50.0%)
$26.07 M(-25.8%)
Sept 2023
-
$35.14 M(-12.7%)
June 2023
-
$40.27 M(-11.9%)
Mar 2023
-
$45.68 M(-12.5%)
Dec 2022
$52.19 M(-33.9%)
$52.19 M(-10.7%)
Sept 2022
-
$58.42 M(-12.0%)
June 2022
-
$66.36 M(-8.7%)
Mar 2022
-
$72.67 M(-8.0%)
Dec 2021
$78.99 M(+344.8%)
$78.99 M(-2.8%)
Sept 2021
-
$81.26 M(-4.1%)
June 2021
-
$84.70 M(-4.3%)
Mar 2021
-
$88.52 M(+398.4%)
Dec 2020
$17.76 M
$17.76 M(+22.8%)
Sept 2020
-
$14.47 M(-7.4%)
June 2020
-
$15.63 M(+2.2%)
DateAnnualQuarterly
Mar 2020
-
$15.29 M(-1.8%)
Dec 2019
$15.57 M(+9.1%)
$15.57 M(-17.9%)
Sept 2019
-
$18.98 M(-14.1%)
June 2019
-
$22.09 M(+50.5%)
Mar 2019
-
$14.68 M(+2.9%)
Dec 2018
$14.27 M(-16.6%)
$14.27 M(-4.6%)
Sept 2018
-
$14.97 M(-10.6%)
June 2018
-
$16.75 M(-18.6%)
Mar 2018
-
$20.57 M(+20.2%)
Dec 2017
$17.12 M(+14.4%)
$17.12 M(-8.2%)
Sept 2017
-
$18.65 M(-3.2%)
June 2017
-
$19.27 M(+19.4%)
Mar 2017
-
$16.14 M(+7.9%)
Dec 2016
$14.96 M(-2108.9%)
$14.96 M(-7.9%)
Sept 2016
-
$16.24 M(-5.7%)
June 2016
-
$17.23 M(-2603.4%)
Mar 2016
-
-$688.30 K
Dec 2015
-$744.70 K
-

FAQ

  • What is Moleculin Biotech annual stockholders equity?
  • What is the all time high annual shareholders equity for Moleculin Biotech?
  • What is Moleculin Biotech annual shareholders equity year-on-year change?
  • What is Moleculin Biotech quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Moleculin Biotech?
  • What is Moleculin Biotech quarterly shareholders equity year-on-year change?

What is Moleculin Biotech annual stockholders equity?

The current annual shareholders equity of MBRX is $26.07 M

What is the all time high annual shareholders equity for Moleculin Biotech?

Moleculin Biotech all-time high annual stockholders equity is $78.99 M

What is Moleculin Biotech annual shareholders equity year-on-year change?

Over the past year, MBRX annual stockholders equity has changed by -$26.12 M (-50.04%)

What is Moleculin Biotech quarterly stockholders equity?

The current quarterly shareholders equity of MBRX is $7.48 M

What is the all time high quarterly shareholders equity for Moleculin Biotech?

Moleculin Biotech all-time high quarterly stockholders equity is $88.52 M

What is Moleculin Biotech quarterly shareholders equity year-on-year change?

Over the past year, MBRX quarterly stockholders equity has changed by -$14.11 M (-65.35%)